Subscribe to our Newsletters !!
Alcohol-based solvents and cleaning agents are pop
Biotech Fluidics offers a range of non-invasive fl
The recent rabies death of an 11 year old Canadian
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Micro
Alembic Pharmaceuticals on Friday said it has gotten foundation examination report (EIR) from the US wellbeing controller for its Panelav office in Gujarat.
The organization has gotten EIR from the US Food and Drug Administration (USFDA) for the investigation completed by them on its general oral strong detailing office at Panelav, from March 9 to March 13, Alembic Pharmaceuticals said in a recording to the BSE.
“With this, EIR is set up for all our assembling offices for worldwide markets,” it included.
Portions of Alembic Pharmaceuticals were exchanging at Rs 940.05 per scrip on the BSE, up 3.50 percent from its past close. PTI AKT HRS
